Across
- 2. Should be taken with the first bite of food
- 7. analogs, These medications have a MOA similar to sulfonylureas and tend to increase meal-related insulin secretion
- 10. Can cause fluid retention and macular edema
- 12. Use of this medicine in patients with renal impairment or with excess alcohol intake can cause lactic acidosis
- 15. mimetics, Slow down the digestion of food so that glucose from your meals takes longer to be absorbed, reducing appetite and can result in weight loss
- 16. You ensure that your patient understands this medication is to be injected weekly, not daily
- 18. A patient taking this medication should avoid taking NSAIDs
- 19. Decreases hepatic glucose production and improves insulin sensitivity
- 20. infection, Females taking Sodium-Glucose Cotransport Inhibitors need to monitor for genital itching and vaginal discharge due to their increased risk for developing a _________________________
- 21. Should be taken immediately before eating
Down
- 1. Stimulate the release of insulin regardless of glucose intake dramatically increasing the risk of hypoglycemia
- 3. Because they work by stimulating insulin secretion, they are useful only in patients with some beta cell function
- 4. You are concerned for a patient taking this medicine who reports recent swelling of their ankles
- 5. Two medications that have an increased risk for heart failure
- 6. You teach your patient taking this medicine not to mix it with insulin due to their incompatible pH levels
- 8. contrast, Metformin will be stopped prior to the use of _________________ and held for 48 hours after the procedure
- 9. You instruct your patient taking this medicine to report any burning or foul odor with urination to their provider
- 11. Patients taking Sodium-Glucose Cotransport Inhibitors are at increased risk for _____________
- 13. Incretin mimetics should be avoided in patients with _____________________
- 14. A patient taking this medicine is reporting abdominal pain and nausea and you are worried for their increased risk for pancreatitis
- 17. Increases the risk for acute kidney injury and impaired renal function
- 22. Inhibitors, Prevents enzymes from breaking down the GLP-1 hormone